COVID-19 Disparities Widened by Underlying Issues, Lack of Access to Care
A recent study attributed COVID-19 morbidity and mortality disparities to “upstream issues” such as underlying conditions and lack of access to testing and care.
A recent study attributed COVID-19 morbidity and mortality disparities to “upstream issues” such as underlying conditions and lack of access to testing and care.
In patients with Clostridium difficile infection (CDI), ibezapolstat was shown to have similar results to a standard of care therapy.
The investigational vaccine, mRNA-1345, developed for seniors has its FDA PDUFA date in a few days.
Registration Open Registration is now open for the highly anticipated 2024 Annual Conference on Vaccinology Research: Preparing for the Future. Join us online on May…
The investigational vaccine, mRNA-1345, developed for seniors has its FDA PDUFA date in a few days.
Investigating the long-term efficacy beyond short-term benefits.
In patients with Clostridium difficile infection (CDI), ibezapolstat was shown to have similar results to a standard of care therapy.
Despite overall reductions, the elderly remain vulnerable to severe COVID-19 outcomes.
Spare use of carbapenem-sparing regimens reflects practice lagging behind guidance, among the challenges in implementing antimicrobial stewardship.
New data from a World Health Organization (WHO) repository illustrates the treatment challenges during the acute phase of the pandemic.
According to the latest Centers for Disease Control and Prevention (CDC) data, these strains have increased in incidence rates, and now account for nearly a…